Literature DB >> 26411598

[Pseudo-adult Still's disease, anasarca, thrombotic thrombocytopenic purpura and dysautonomia: An atypical presentation of multicentric Castleman's disease. Discussion of TAFRO syndrome].

M Jouvray1, L Terriou1, V Meignin2, B Bouchindhomme3, M Jourdain4, M Lambert1, G Lefevre5, E Hachulla5, P-Y Hatron1, L Galicier6, D Launay7.   

Abstract

INTRODUCTION: Multicentric Castleman's disease can mimic adult-onset Still disease. It is exceptionally associated with anasarca, thrombotic microangiopathy and dysautonomia. CASE REPORT: We report a 32-year-old woman with an association of oligoanuria, anasarca, thrombotic microangiopathy with features compatible with adult-onset Still disease. The outcome was initially favorable with corticosteroids, immunoglobulins and plasmapheresis but with the persistence of relapses marked by severe autonomic syndrome and necessity of high dose corticosteroids. The diagnosis of mixed type Castleman's disease, HHV8 and HIV negative, was obtained four years after the onset of symptoms by a lymph node biopsy. The outcome was favorable after tocilizumab and corticosteroids but tocilizumab had to be switched to anakinra to ensure a proper and long-lasting control of the disease.
CONCLUSION: Our patient partially fits the description of TAFRO syndrome (Thrombocytopenia, Anasarca, myeloFibrosis, Renal dysfunction, Organomegaly), a MCM rare variant, recently described in Japanese patients.
Copyright © 2015 Société nationale française de médecine interne (SNFMI). Published by Elsevier SAS. All rights reserved.

Entities:  

Keywords:  Adult-onset Still's disease; Dysautonomia; Dysautonomie; Maladie de Castleman multicentrique; Maladie de Still de l’adulte; Microangiopathie thrombotique; Multicentric Castleman's disease; Syndrome TAFRO; TAFRO syndrome; Thrombotic thrombocytopenic purpura

Mesh:

Year:  2015        PMID: 26411598     DOI: 10.1016/j.revmed.2015.04.006

Source DB:  PubMed          Journal:  Rev Med Interne        ISSN: 0248-8663            Impact factor:   0.728


  5 in total

1.  Aggressive TAFRO syndrome with reversible cardiomyopathy successfully treated with combination chemotherapy.

Authors:  Shunichiro Yasuda; Keisuke Tanaka; Ayako Ichikawa; Ken Watanabe; Emi Uchida; Masahide Yamamoto; Kouhei Yamamoto; Daisuke Mizuchi; Osamu Miura; Tetsuya Fukuda
Journal:  Int J Hematol       Date:  2016-05-31       Impact factor: 2.490

2.  Two Cases of Thrombocytopenia, Anasarca, Fever, Reticulin Fibrosis/Renal Failure, and Organomegaly (TAFRO) Syndrome with High Serum Procalcitonin Levels, Including the First Case Complicated with Adrenal Hemorrhaging.

Authors:  Mizuho Nara; Atsushi Komatsuda; Fumiko Itoh; Hajime Kaga; Masaya Saitoh; Masaru Togashi; Yoshihiro Kameoka; Hideki Wakui; Naoto Takahashi
Journal:  Intern Med       Date:  2017-05-15       Impact factor: 1.271

Review 3.  Idiopathic multicentric Castleman's disease: a systematic literature review.

Authors:  Amy Y Liu; Christopher S Nabel; Brian S Finkelman; Jason R Ruth; Razelle Kurzrock; Frits van Rhee; Vera P Krymskaya; Dermot Kelleher; Arthur H Rubenstein; David C Fajgenbaum
Journal:  Lancet Haematol       Date:  2016-03-17       Impact factor: 18.959

4.  TAFRO Syndrome in Caucasians: A Case Report and Review of the Literature.

Authors:  Céline Louis; Sandrine Vijgen; Kaveh Samii; Yves Chalandon; Louis Terriou; David Launay; David C Fajgenbaum; Jörg D Seebach; Yannick D Muller
Journal:  Front Med (Lausanne)       Date:  2017-09-22

5.  Membranoproliferative glomerulonephritis-like findings for TAFRO syndrome, associated with an anterior mediastinal tumor: A case report.

Authors:  Yoshitaka Furuto; Hirotsugu Hashimoto; Hajime Horiuti; Yuko Shibuya
Journal:  Medicine (Baltimore)       Date:  2018-06       Impact factor: 1.889

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.